Related Experiment Video
Updated: Jun 13, 2025
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
[The characteristics of pediatric-onset inflammatory bowel disease based on our 20-year-long study]
11 Semmelweis Egyetem, Általános Orvostudományi Kar, Gyermekgyógyászati Klinika, MTA Kiváló Kutatóhely Budapest, Postafiók 2., 1428 Magyarország.
Insights
Pediatric inflammatory bowel diseases (IBD) present unique challenges, including complex progression and diagnostic delays. Early awareness of these specific characteristics is vital for improving outcomes in children and adolescents with IBD.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Pediatrics
Background:
- Pediatric inflammatory bowel diseases (IBD) account for 10% of all IBD cases.
- Childhood-onset IBD often involves a more complex disease course, extensive inflammation, and rapid progression.
- Nonspecific presenting symptoms and diagnostic delays in pediatric IBD increase risks of intestinal damage, surgery, and growth issues.
Purpose of the Study:
- To highlight the distinct clinical characteristics of pediatric-onset inflammatory bowel diseases.
- To emphasize the importance of physician awareness regarding the specific challenges in managing IBD in children and adolescents.
- To underscore the need for optimized disease management strategies in young IBD patients.
Main Methods:
- Review of clinical data and disease progression in pediatric inflammatory bowel disease patients.
- Analysis of common symptoms, diagnostic challenges, and treatment adherence in adolescents with IBD.
- Evaluation of extraintestinal complications and healthcare utilization in the pediatric IBD population.
Main Results:
- Pediatric IBD is associated with a more aggressive disease course, higher rates of intestinal damage, and frequent need for surgical intervention.
- Adolescents with IBD demonstrate the lowest medication adherence, leading to increased complications.
- Significant extraintestinal manifestations include growth retardation, malnutrition, bone metabolism impairment, malignancies, and opportunistic infections.
Conclusions:
- Pediatric-onset inflammatory bowel diseases require specialized management due to their unique complexities and higher complication rates.
- Physicians must possess a thorough understanding of pediatric IBD specifics to ensure optimal patient outcomes and quality of life.
- Early recognition and tailored treatment strategies are crucial for mitigating long-term adverse effects in young IBD patients.
Abstract:
Among inflammatory bowel diseases (IBDs), every tenth develops during childhood, which is characterized by a more complex disease course, more extensive spread, and rapid progression. The presenting symptoms of pediatric-onset IBD are often nonspecific, and diagnostic delays increase the risk of intestinal damage, bowel resection, and growth retardation. Adolescents with IBD exhibit the lowest compliance and medication adherence rates, contributing to the frequent occurrence of complications. The most significant extraintestinal complications in pediatric-onset IBD patients include growth retardation, malnutrition, impaired bone metabolism, malignancies, and opportunistic infections. In this patient group, surgical interventions are required earlier and more frequently, and the hospitalization rate is also higher among them. Ensuring optimal disease progression and quality of life is crucial, making it essential for the physicians managing their care to be well aware of the specific characteristics of the pediatric-onset IBD patient group. Orv Hetil. 2025; 166(11): 403–412.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...